[1]
“RP-HPLC Method Development and Validation for Simultaneous Estimation of Erlotinib and Ramucirumab in bulk and Pharmaceutical Dosage form  and its stability studies”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 3, pp. 452–457, May 2024, doi: 10.25004/IJPSDR.2024.160318.